Lazard Asset Management
LENZ

Lazard Asset Management’s LENZ Therapeutics LENZ Stock Holding History

Lazard Asset Management’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.8K Buy
+12,990
New +$105K ﹤0.01% 1785
2024
Q3 		– Sell
-12
Closed – – 2480
2024
Q2 		$0 Sell
12
-276
-96% -$4.82K ﹤0.01% 2456
2024
Q1 		$6K Sell
288
-122
-30% -$2.54K ﹤0.01% 1896
2023
Q4 		$7K Sell
410
-24
-6% -$396 ﹤0.01% 2110
2023
Q3 		$7K Buy
434
+21
+5% +$365 ﹤0.01% 2170
2023
Q2 		$7K Buy
413
+25
+6% +$500 ﹤0.01% 2200
2023
Q1 		$6K Buy
388
+73
+23% +$1.18K ﹤0.01% 2159
2022
Q4 		$7K Buy
+315
New +$7.3K ﹤0.01% 2240

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Lazard Asset Management's LENZ Position: Q2 2026 in Review

Lazard Asset Management opened a new position in LENZ Therapeutics (LENZ) in Q2 2026: 12,990 shares worth $73.8K. The stake represents ﹤0.01% of the portfolio and ranks #1785 among its holdings. This is a return to the name: Lazard Asset Management previously reported a position in LENZ as recently as Q2 2024.

Lazard Asset Management first reported a position in LENZ in Q4 2022 and has held it in 8 quarters since. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Lazard Asset Management held 12,990 shares of LENZ Therapeutics worth $73.8K as of Q2 2026.
  • LENZ Therapeutics was a new Lazard Asset Management position in Q2 2026.
  • LENZ Therapeutics made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1785 holding.
  • Lazard Asset Management first reported a position in LENZ Therapeutics in Q4 2022 and has held it in 8 quarters since.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.